Page 2 - Alex Leech News Today

Lough Ree mostly laid on two days of lively clearview sailing

LDYC Commodore Joe Gilmartin welcomed a strong fleet across four keelboat classes

The weekend culminated on Sunday with racing but of course nothing ordinary!

Posted on 802 Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, today announces the completion of a £60 million ($82 million) Series A financing round. The international investment syndicate is led by RA Capital Management, with participation from Lightstone Ventures, Data Collective VC (DCVC), DHVC, SV Health Invest...

Alchemab Therapeutics Raises £60M in Series A Financing Alchemab Therapeutics, a Cambridge, England, UK-based biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies, completed a £60m ($82m) Series A financing round. The round was led by RA Capital Management, with participation from Lightstone Ventures, Data Collective VC (DCVC), DHVC, SV Health Investors and the Dementia Discovery Fund. The company, which was created by SV Health I...

Alchemab Raises $82 Million to Advance Antibody Therapeutics in Neurodegeneration and Cancer Share Rare Daily Staff Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, said it closed an $82 million (£60 million) series A financing round. RA Capital Management led the financing, with participation by an international syndicate that included Lightstone Ventures, Dat...